Everyone Is Talking About Monoclonal Antibodies as Treatment For Reducing Risk of Symptomatic COVID — Is It an Option for Those With Cancer?

Published Jan 26, 2021

Everyone Is Talking About Monoclonal Antibodies as Treatment For Reducing Risk of Symptomatic COVID — Is It an Option for Those With Cancer?

There is a lot of talk around monoclonal antibodies and how they might be able to help those with COVID-19. While there is much to understand around how it works and if it's right for those fighting cancer, the outlook is positive.

NOW
PLAYING
Study Links Cancer Treatment Drugs to Lower Risk of COVID-19 Infection
NOW
PLAYING
A Leukemia Patient Unable to Get Vaccinated Has Died from COVID at 41; Should People with Blood Cancer Get the Vaccine?
NOW
PLAYING
COVID Booster Shots Approved for Cancer Patients, Other Immunocompromised Americans; No Prescription, ID is Required
NOW
PLAYING
FDA Set to Approve Third COVID-19 Booster Shot For Cancer Patients
NOW
PLAYING
COVID Patients Mental, Physical Declines Greater Than Cancer Patients
NOW
PLAYING
Does Your Cancer Center Require Employees To Be Vaccinated? How Cancer Patients Can Stay Safe From The Delta Variant During COVID-19

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.